African Pharmaceuticals Market, Forecast to 2020

African Pharmaceuticals Market, Forecast to 2020

Assessing Market Potential with a Focus on Kenya and Nigeria

RELEASE DATE
21-Dec-2016
REGION
Africa
Research Code: MC24-01-00-00-00
SKU: HC02697-AF-MR_19227

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02697-AF-MR_19227

$4,950.00

$3,712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

The pharmaceuticals market in Africa is expected to reach a business opportunity of $45 billion in 2020, propelled by a convergence of changing economic profiles, rapid urbanisation, increased healthcare spending and investment, and increasing incidence of chronic lifestyle diseases.
The tropical climate of Africa makes the continent the largest reservoir of infectious diseases, particularly malaria, tuberculosis (TB), and acquired immune deficiency syndrome (AIDS), besides frequent outbreaks of polio, meningitis, cholera, pandemic influenza, yellow fever, measles, hepatitis, and tetanus. With the increasing adoption of Western lifestyle in Africa, there has been a paradigm shift in the burden of illness towards non-communicable diseases (NCDs), driving the demand for chronic prescription drugs. While continuing to suffer from infectious and parasitic illness, lifestyle diseases such as cardiovascular diseases, diabetes, and cancer will witness high growth rates throughout the forecast period. The World Health Organisation predicts that the proportional contribution of NCDs to the healthcare burden in Africa will rise by 21% through 2030. The growing middle class is a key driving force for pharmaceuticals spending. Limited affordability of governments and the general population for healthcare and pharmaceuticals and a high reliance on donor funding will be the major market restraints.

RESEARCH: INFOGRAPHIC

This infographic presents a brief overview of the research, and highlights the key topics discussed in it.
Click image to view it in full size

Table of Contents

Market Themes

Key Findings

Overview

Key Products and Segments

Impact of Healthcare Industry Mega Trends on the SSA Pharmaceuticals Market

Pharmaceutical Imports

Revenue Forecast

Key Challenges in African Pharmaceuticals Manufacturing

Key Challenges in African Pharmaceuticals Supply Chain

Market Overview

Market Segmentation—Prescription Vs OTC

Market Segmentation and Size—Generic Vs Branded

Prescription Market—Revenue Breakdown by Therapeutic Segments

Prescription Market—Percent Revenue Breakdown by Products

OTC Market—Revenue Breakdown by Therapeutic Segments

Purchasing and Procurement

Pharmaceuticals Market Trends

Market Drivers

Market Restraints

Pricing Analysis

Regulatory Environment

Pharmaceuticals Market—List of Key Participants

Nigeria—Competitive Factors and Assessment

Market Overview

Market Segmentation—Prescription Vs OTC

Market Segmentation and Size—Generic Vs Branded

Prescription Market—Revenue Breakdown by Therapeutic Segments

Prescription Market—Percent Revenue Breakdown by Products

OTC Market—Revenue Breakdown by Therapeutic Segments

Purchasing and Procurement

Pharmaceuticals Market Trends

Market Drivers

Market Restraints

Pricing Analysis

Regulatory Environment

Pharmaceuticals Market—List of Key Participants

Kenya—Competitive Factors and Assessment

Key Areas of Focus for Pharmaceutical Portfolio

Pharmaceutical Manufacturing

Conclusions and Recommendations

The Last Word—3 Big Predictions

The Last Word—Discussion

Legal Disclaimer

List of Figures
  • 1. Total Pharmaceuticals Market: Products and Segment Definitions, Africa, 2015
  • 2. Pharmaceuticals Market: Variables Impacting the Market, Nigeria, 2015
  • 3. Pharmaceuticals Market: Key Market Drivers, Nigeria, 2016–2020
  • 4. Pharmaceuticals Market: Key Market Restraints, Nigeria, 2016–2020
  • 5. Pharmaceuticals Market: Pricing Analysis, Nigeria, 2015
  • 6. Pharmaceuticals Market: List of Regulatory Bodies and their Responsibilities, Nigeria, 2015
  • 7. Pharmaceuticals Market: List of Key Generic Participants, Nigeria, 2015
  • 8. Pharmaceuticals Market: List of Key Branded Participants, Nigeria, 2015
  • 9. Pharmaceuticals Market: Variables Impacting the Market, Kenya, 2015
  • 10. Pharmaceuticals Market: Key Market Drivers, Kenya, 2016–2020
  • 11. Pharmaceuticals Market: Key Market Restraints, Kenya, 2016–2020
  • 12. Pharmaceuticals Market: Pricing Analysis, Kenya, 2015
  • 13. Pharmaceuticals Market: List of Regulatory Bodies and their Responsibilities, Kenya, 2015
  • 14. Pharmaceuticals Market: List of Key Generic Participants, Kenya, 2015
  • 15. Pharmaceuticals Market: List of Key Branded Participants, Kenya, 2015
  • 16. Key Areas of Focus Within Prescription Drugs Market, Nigeria and Kenya, 2015
  • 17. Key Areas of Focus Within OTC Products Market, Nigeria and Kenya, 2015
List of Charts
  • 1. Total Pharmaceuticals Market: Leading Causes of Death, Africa, 2010
  • 2. Total Pharmaceuticals Market: Leading Causes of Death, Africa, 2030
  • 3. Total Pharmaceuticals Market: Pharmaceutical Spending, Africa, 2014–2020
  • 4. Total Pharmaceuticals Market: Imports—Percent Share by Type, Sub-Saharan Africa, 2014
  • 5. Total Pharmaceuticals Market: Imports—Percent Share by Country, Sub-Saharan Africa, 2014
  • 6. Total Pharmaceuticals Market: Revenue Forecast, Africa*, 2015–2020
  • 7. Prescription Market: Revenue Breakdown by Products, Nigeria, 2015
  • 8. Prescription Market: Percent Revenue Breakdown by Product Segments, Nigeria, 2015
  • 9. Prescription Market: Revenue Breakdown by Therapeutic Segments, Nigeria, 2015
  • 10. Prescription Market: Percent Revenue Breakdown by Products, Nigeria, 2015
  • 11. OTC Market: Revenue Breakdown by Therapeutic Segments, Nigeria, 2015
  • 12. Pharmaceuticals Market: Purchasing Value Chain—Private and Public Sector, Nigeria, 2015
  • 13. Pharmaceuticals Market: Revenue Breakdown by Segments, Kenya, 2015
  • 14. Prescription Market: Revenue Breakdown by Products, Kenya, 2015
  • 15. Prescription Market: Percent Revenue Breakdown by Product Segments, Kenya, 2015
  • 16. Prescription Market: Revenue Breakdown by Therapeutic Segments, Kenya, 2015
  • 17. Prescription Market: Percent Revenue Breakdown by Products, Kenya, 2015
  • 18. Pharmaceuticals Market: Purchasing Value Chain—Private and Public Sector, Kenya, 2015
  • 19. Pharmaceuticals Market: Percent Breakdown by Segments, Nigeria and Kenya, 2015
Related Research
The pharmaceuticals market in Africa is expected to reach a business opportunity of $45 billion in 2020, propelled by a convergence of changing economic profiles, rapid urbanisation, increased healthcare spending and investment, and increasing incidence of chronic lifestyle diseases. The tropical climate of Africa makes the continent the largest reservoir of infectious diseases, particularly malaria, tuberculosis (TB), and acquired immune deficiency syndrome (AIDS), besides frequent outbreaks of polio, meningitis, cholera, pandemic influenza, yellow fever, measles, hepatitis, and tetanus. With the increasing adoption of Western lifestyle in Africa, there has been a paradigm shift in the burden of illness towards non-communicable diseases (NCDs), driving the demand for chronic prescription drugs. While continuing to suffer from infectious and parasitic illness, lifestyle diseases such as cardiovascular diseases, diabetes, and cancer will witness high growth rates throughout the forecast period. The World Health Organisation predicts that the proportional contribution of NCDs to the healthcare burden in Africa will rise by 21% through 2030. The growing middle class is a key driving force for pharmaceuticals spending. Limited affordability of governments and the general population for healthcare and pharmaceuticals and a high reliance on donor funding will be the major market restraints.--BEGIN PROMO--


Africa is in a transition phase, on its way to achieving adherence to global standards, such as the WHO pre-qualification for manufacturing. Local production is regarded as a key strategy for sustained access to quality-assured medicines for the long term. The regulatory environment for manufacturing in regions such as East Africa seems to grow rapidly, owing to regional harmonisation. Healthcare coverage is expected to expand to a greater proportion of the population through National Health Insurance (NHI) initiatives, as well as through memberships with privat

More Information
No Index No
Podcast No
Table of Contents | Executive Summary~ || Market Themes~ || Key Findings~ | Market Overview~ || Overview~ || Key Products and Segments~ || Impact of Healthcare Industry Mega Trends on the SSA Pharmaceuticals Market~ || Pharmaceutical Imports~ || Revenue Forecast~ || Key Challenges in African Pharmaceuticals Manufacturing~ || Key Challenges in African Pharmaceuticals Supply Chain~ | Market Analysis—Nigeria~ || Market Overview~ || Market Segmentation—Prescription Vs OTC~ || Market Segmentation and Size—Generic Vs Branded~ || Prescription Market—Revenue Breakdown by Therapeutic Segments~ || Prescription Market—Percent Revenue Breakdown by Products~ || OTC Market—Revenue Breakdown by Therapeutic Segments~ || Purchasing and Procurement~ || Pharmaceuticals Market Trends~ || Market Drivers~ || Market Restraints~ || Pricing Analysis~ || Regulatory Environment~ || Pharmaceuticals Market—List of Key Participants~ || Nigeria—Competitive Factors and Assessment~ | Market Analysis—Kenya~ || Market Overview~ || Market Segmentation—Prescription Vs OTC~ || Market Segmentation and Size—Generic Vs Branded~ || Prescription Market—Revenue Breakdown by Therapeutic Segments~ || Prescription Market—Percent Revenue Breakdown by Products~ || OTC Market—Revenue Breakdown by Therapeutic Segments~ || Purchasing and Procurement~ || Pharmaceuticals Market Trends~ || Market Drivers~ || Market Restraints~ || Pricing Analysis~ || Regulatory Environment~ || Pharmaceuticals Market—List of Key Participants~ || Kenya—Competitive Factors and Assessment~ | Conclusions and Recommendations~ || Key Areas of Focus for Pharmaceutical Portfolio~ || Pharmaceutical Manufacturing~ || Conclusions and Recommendations~ | The Last Word~ || The Last Word—3 Big Predictions~ || The Last Word—Discussion~ || Legal Disclaimer~ | Market Engineering Methodology~
List of Charts and Figures 1. Total Pharmaceuticals Market: Products and Segment Definitions, Africa, 2015~ 2. Pharmaceuticals Market: Variables Impacting the Market, Nigeria, 2015~ 3. Pharmaceuticals Market: Key Market Drivers, Nigeria, 2016–2020~ 4. Pharmaceuticals Market: Key Market Restraints, Nigeria, 2016–2020 ~ 5. Pharmaceuticals Market: Pricing Analysis, Nigeria, 2015~ 6. Pharmaceuticals Market: List of Regulatory Bodies and their Responsibilities, Nigeria, 2015~ 7. Pharmaceuticals Market: List of Key Generic Participants, Nigeria, 2015~ 8. Pharmaceuticals Market: List of Key Branded Participants, Nigeria, 2015~ 9. Pharmaceuticals Market: Variables Impacting the Market, Kenya, 2015~ 10. Pharmaceuticals Market: Key Market Drivers, Kenya, 2016–2020~ 11. Pharmaceuticals Market: Key Market Restraints, Kenya, 2016–2020 ~ 12. Pharmaceuticals Market: Pricing Analysis, Kenya, 2015~ 13. Pharmaceuticals Market: List of Regulatory Bodies and their Responsibilities, Kenya, 2015~ 14. Pharmaceuticals Market: List of Key Generic Participants, Kenya, 2015~ 15. Pharmaceuticals Market: List of Key Branded Participants, Kenya, 2015~ 16. Key Areas of Focus Within Prescription Drugs Market, Nigeria and Kenya, 2015~ 17. Key Areas of Focus Within OTC Products Market, Nigeria and Kenya, 2015~| 1. Total Pharmaceuticals Market: Leading Causes of Death, Africa, 2010~ 2. Total Pharmaceuticals Market: Leading Causes of Death, Africa, 2030~ 3. Total Pharmaceuticals Market: Pharmaceutical Spending, Africa, 2014–2020~ 4. Total Pharmaceuticals Market: Imports—Percent Share by Type, Sub-Saharan Africa, 2014~ 5. Total Pharmaceuticals Market: Imports—Percent Share by Country, Sub-Saharan Africa, 2014~ 6. Total Pharmaceuticals Market: Revenue Forecast, Africa*, 2015–2020~ 7. Prescription Market: Revenue Breakdown by Products, Nigeria, 2015~ 8. Prescription Market: Percent Revenue Breakdown by Product Segments, Nigeria, 2015~ 9. Prescription Market: Revenue Breakdown by Therapeutic Segments, Nigeria, 2015~ 10. Prescription Market: Percent Revenue Breakdown by Products, Nigeria, 2015~ 11. OTC Market: Revenue Breakdown by Therapeutic Segments, Nigeria, 2015~ 12. Pharmaceuticals Market: Purchasing Value Chain—Private and Public Sector, Nigeria, 2015~ 13. Pharmaceuticals Market: Revenue Breakdown by Segments, Kenya, 2015~ 14. Prescription Market: Revenue Breakdown by Products, Kenya, 2015~ 15. Prescription Market: Percent Revenue Breakdown by Product Segments, Kenya, 2015~ 16. Prescription Market: Revenue Breakdown by Therapeutic Segments, Kenya, 2015~ 17. Prescription Market: Percent Revenue Breakdown by Products, Kenya, 2015~ 18. Pharmaceuticals Market: Purchasing Value Chain—Private and Public Sector, Kenya, 2015~ 19. Pharmaceuticals Market: Percent Breakdown by Segments, Nigeria and Kenya, 2015~ 20.
Lightbox Content World Cancer Day 2019|Get 15% discount for all Healthcare studies |https://store.frost.com/contacts/?utm_source=PD&utm_medium=lightbox&utm_campaign=HEALTHCARE_CANCER2019
Author Saravanan Thangaraj
Industries Healthcare
WIP Number MC24-01-00-00-00
Is Prebook No